Skip to content
Screener

Precigen PGEN Q1 2026 earnings

Reported May 13, 2026 · After market close

Revenue$23.3MBeat by $2.4M
EPS-$0.02Beat by $0.01
Revenue estimate$20.8M
EPS estimate-$0.03

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$69.2M
EPS estimate$0.09

Financials

Q1 2026

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.37B+213%
Enterprise value$1.46B+234%

Returns & leverage

See full
Debt / equity4.9×—
Current ratio4.8×+1.3×

Segments

By product

See full
Papzimeos$21.6M—

FAQ

When did Precigen report Q1 2026 earnings?
Precigen (PGEN) reported Q1 2026 earnings on May 13, 2026 after market close.
What were Precigen's Q1 2026 revenue and EPS?
Precigen reported revenue of $23.3M and eps of $-0.02 for Q1 2026.
Did Precigen beat estimates in Q1 2026?
Revenue beat the consensus estimate of $20.8M by $2.4M. EPS beat the consensus estimate of $-0.03 by $0.01.
How did Precigen's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1633.9% from $1.3M a year earlier and eps grew 71.4% from $-0.07.
Where can I find Precigen's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000950103-26-007158) and the 10-Q periodic report (0001356090-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.